Quantitative benefit-risk tradeoff preferences for Crohn's disease treatments – implications for regulatory decision making and disease management

Albert H. Hauber; F. Reed Johnson; Semra Ozdemir; F. Reed Johnson; Brett Hauber; Semra Ozdemir; Steve Hass; Corey Siegel; Bruce Sands

Quantitative benefit-risk tradeoff preferences for Crohn's disease treatments – implications for regulatory decision making and disease management

Johnson, F., Hauber, A., Ozdemir, S., Hass, S., Siegel, C., & Sands, B. (2009). Quantitative benefit-risk tradeoff preferences for Crohn's disease treatments – implications for regulatory decision making and disease management. International Journal of Medical and Biological Frontiers, 15(5/6), 457-66.

Copy citation